DAVID
NAVARRO ORTEGA
CATEDRÁTICO/A DE UNIVERSIDAD
![Foto de DAVID](/img/nophoto.png)
![Foto de Hospital Universitario Son Espases](/img/noimage_org.png)
Hospital Universitario Son Espases
Palma, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitario Son Espases (16)
2021
-
Spread of a SARS-CoV-2 variant through Europe in the summer of 2020
Nature, Vol. 595, Núm. 7869, pp. 707-712
-
The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant
Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414
2019
-
Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain
Open Forum Infectious Diseases, Vol. 6, Núm. 2
2017
-
HIV type 2 epidemic in Spain: Challenges and missing opportunities
AIDS, Vol. 31, Núm. 10, pp. 1353-1364
-
Human T-lymphotropic virus type 1 infection and disease in Spain
AIDS, Vol. 31, Núm. 12, pp. 1653-1663
-
Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?
Annals of Hematology, Vol. 96, Núm. 8, pp. 1253-1270
2016
-
Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders
Blood Reviews, Vol. 30, Núm. 1, pp. 35-48
2015
-
Cytomegalovirus prevention strategies in seropositive kidney transplant recipients: An insight into current clinical practice
Transplant International, Vol. 28, Núm. 9, pp. 1042-1054
2013
-
Erratum: Pathogen safety of long-term treatments for bleeding disorders: (Un)predictable risks and evolving threats (Seminars in Thrombosis and Hemostasis (2013) 39 (973))
Seminars in Thrombosis and Hemostasis
-
Pathogen safety of long-term treatments for bleeding disorders: (Un)Predictable risks and evolving threats
Seminars in Thrombosis and Hemostasis, Vol. 39, Núm. 7, pp. 779-793
-
Pathogen safety of long-term treatments for bleeding disorders: Still relevant to current practice
Haematologica
2012
-
Comparison of three statistical methods for establishing tentative wild-type population and epidemiological cutoff values for echinocandins, amphotericin B, flucytosine, and six Candida species as determined by the colorimetric sensititre yeastone method
Journal of Clinical Microbiology, Vol. 50, Núm. 12, pp. 3921-3926
-
Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey
Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 5, pp. 1181-1187
2011
-
GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients Recomendaciones GESITRA-SEIMC/REIPI para el manejo de la infección por citomegalovirus en pacientes trasplantados de órgano sólido
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 10, pp. 735-758
-
Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia
Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 12, pp. 5590-5596
2007
-
Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)
Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229